Addyi was 1st permitted via the FDA in August 2015 to treat hypoactive sexual need dysfunction (HSDD) in premenopausal Women of all ages. Which is just yet another way of claiming it boosts sexual intercourse travel (also called libido) in women that have not attained menopause. It was the initial https://douglasg285oon1.wikinewspaper.com/user